Your Article Summary
See Latest ArticlesRenal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
New England Journal of Medicine, 07/02/09
Mauer M et al. - Early blockade of the renin–angiotensin system in patients with type 1 diabetes did not slow nephropathy progression but slowed the progression of retinopathy.
Related Articles
Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease
Nephrology Dialysis Transplantation, 11/17/09
Relevance Score: 84%
Pseudomelanosis Duodeni: An Unusual Finding From Upper Gastrointestinal Endoscopy
Clinical Gastroenterology and Hepatology, 11/04/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration
Journal of Clinical Ultrasound, 12/03/09
N-Acetylcarnosine Lubricant Eyedrops Possess All-In-One Universal Antioxidant Protective Effects of L-Carnosine in Aqueous and Lipid Membrane Environments, Aldehyde Scavenging, and Transglycation Activities Inherent to Cataracts: A Clinical Study of the New Vision-Saving Drug N-Acetylcarnosine Eyedrop Therapy in a Database Population of Over 50,500 Patients
American Journal of Therapeutics, 12/02/09
Photodynamic Therapy With and Without Adjunctive Intravitreal Triamcinolone Acetonide
Ophthalmic Surgery, Lasers and Imaging, 12/01/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of inflammation in the pathogenesis of age-related macular degeneration
Expert Review of Ophthalmology, 12/07/09
Pathophysiology and management of diabetic retinopathy
Expert Review of Ophthalmology, 12/07/09
Treatment of branch retinal vein occlusion
Expert Review of Ophthalmology, 12/07/09